Evoke Pharma Inc
NASDAQ:EVOK

Watchlist Manager
Evoke Pharma Inc Logo
Evoke Pharma Inc
NASDAQ:EVOK
Watchlist
Price: 3.09 USD Market Closed
Market Cap: 4.6m USD

Intrinsic Value

EVOK doesn't have a meaningful market cap.

The intrinsic value of one EVOK stock under the Base Case scenario is 80.3 USD. Compared to the current market price of 3.09 USD, Evoke Pharma Inc is Undervalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EVOK Intrinsic Value
80.3 USD
Undervaluation 96%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

Evoke Pharma Inc
NASDAQ:EVOK
US
Pharmaceuticals
Market Cap
4.6m USD
IPO
Sep 25, 2013
US
Pharmaceuticals
Market Cap
4.6m USD
IPO
Sep 25, 2013
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Evoke Pharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Evoke Pharma Inc

Current Assets 17.2m
Cash & Short-Term Investments 13.6m
Receivables 2.4m
Other Current Assets 1.2m
Non-Current Assets 281.1k
PP&E 154.2k
Other Non-Current Assets 126.9k
Efficiency

Free Cash Flow Analysis
Evoke Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Evoke Pharma Inc

Revenue
10.2m USD
Cost of Revenue
-356.5k USD
Gross Profit
9.9m USD
Operating Expenses
-15.1m USD
Operating Income
-5.2m USD
Other Expenses
-148.1k USD
Net Income
-5.4m USD
Fundamental Scores

EVOK Profitability Score
Profitability Due Diligence

Evoke Pharma Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
34/100
Profitability
Score

Evoke Pharma Inc's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

EVOK Solvency Score
Solvency Due Diligence

Evoke Pharma Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
50/100
Solvency
Score

Evoke Pharma Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EVOK Price Targets Summary
Evoke Pharma Inc

Wall Street analysts forecast EVOK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVOK is 18.36 USD with a low forecast of 18.18 USD and a high forecast of 18.9 USD.

Lowest
Price Target
18.18 USD
488% Upside
Average
Price Target
18.36 USD
494% Upside
Highest
Price Target
18.9 USD
512% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Evoke Pharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EVOK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

EVOK Insider Trading
Buy and sell transactions by insiders